288 related articles for article (PubMed ID: 29135584)
1. Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy.
Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; de Wit J; Carr A;
AIDS; 2018 Jan; 32(1):35-48. PubMed ID: 29135584
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients.
Krentz HB; Gill MJ
AIDS Patient Care STDS; 2016 Jan; 30(1):11-7. PubMed ID: 26544766
[TBL] [Abstract][Full Text] [Related]
3. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients.
Tseng A; Szadkowski L; Walmsley S; Salit I; Raboud J
Ann Pharmacother; 2013 Nov; 47(11):1429-39. PubMed ID: 24285760
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of polypharmacy and pharmacotherapy complexity in elderly people living with HIV in Spain. POINT study.
Gimeno-Gracia M; Sánchez-Rubio-Ferrández J; Robustillo-Cortés MLA; Morillo-Verdugo R
Farm Hosp; 2020 Jul; 44(4):127-134. PubMed ID: 32646344
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter Medications.
Sutherland JJ; Morrison RD; McNaughton CD; Daly TM; Milne SB; Daniels JS; Ryan TP
JAMA Netw Open; 2018 Nov; 1(7):e184196. PubMed ID: 30646345
[TBL] [Abstract][Full Text] [Related]
6. The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
Smith JM; Flexner C
AIDS; 2017 Jun; 31 Suppl 2():S173-S184. PubMed ID: 28471948
[TBL] [Abstract][Full Text] [Related]
7. Impact of polypharmacy on antiretroviral prescription in people living with HIV.
Guaraldi G; Menozzi M; Zona S; Calcagno A; Silva AR; Santoro A; Malagoli A; Dolci G; Mussi C; Mussini C; Cesari M; Khoo SH
J Antimicrob Chemother; 2017 Feb; 72(2):511-514. PubMed ID: 27834193
[TBL] [Abstract][Full Text] [Related]
8. Concomitant herbal medicine and Antiretroviral Therapy (ART) use among HIV patients in Western Uganda: a cross-sectional analysis of magnitude and patterns of use, associated factors and impact on ART adherence.
Lubinga SJ; Kintu A; Atuhaire J; Asiimwe S
AIDS Care; 2012; 24(11):1375-83. PubMed ID: 22292937
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of concomitant medications in older HIV+ patients and comparison with general population.
Gimeno-Gracia M; Crusells-Canales MJ; Javier Armesto-Gómez F; Rabanaque-Hernández MJ
HIV Clin Trials; 2015; 16(3):117-24. PubMed ID: 25978302
[TBL] [Abstract][Full Text] [Related]
10. Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review.
Cattaneo D; Baldelli S; Cozzi V; Clementi E; Marriott DJE; Gervasoni C;
Ther Drug Monit; 2020 Feb; 42(1):64-74. PubMed ID: 31393332
[TBL] [Abstract][Full Text] [Related]
11. Polypharmacy among HIV infected people aged 50 years or older.
Fernández Cañabate S; Ortega Valín L
Colomb Med (Cali); 2019 Sep; 50(3):142-152. PubMed ID: 32284660
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence.
Kim TW; Walley AY; Ventura AS; Patts GJ; Heeren TC; Lerner GB; Mauricio N; Saitz R
AIDS Care; 2018 Feb; 30(2):150-159. PubMed ID: 29034725
[TBL] [Abstract][Full Text] [Related]
13. Financial stress is associated with reduced treatment adherence in HIV-infected adults in a resource-rich setting.
McAllister J; Beardsworth G; Lavie E; MacRae K; Carr A
HIV Med; 2013 Feb; 14(2):120-4. PubMed ID: 22780330
[TBL] [Abstract][Full Text] [Related]
14. Awareness and use of medication management services in relation to medication adherence prior to hospitalisation among older adults in Regional Australia.
Lau KP; Adewumi AD
Int J Clin Pharm; 2019 Feb; 41(1):189-197. PubMed ID: 30535822
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy in HIV: impact of data source and gender on reported drug utilization.
Furler MD; Einarson TR; Walmsley S; Millson M; Bendayan R
AIDS Patient Care STDS; 2004 Oct; 18(10):568-86. PubMed ID: 15630785
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Brazil.
da Silva RPN; Marins LMS; Guaraldo L; Luz PM; Cardoso SW; Moreira RI; Oliveira VDG; Veloso VG; Grinsztejn B; Estrela R; Torres TS
AIDS Res Ther; 2023 Aug; 20(1):57. PubMed ID: 37605195
[TBL] [Abstract][Full Text] [Related]
17. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.
Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT;
J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401
[TBL] [Abstract][Full Text] [Related]
18. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
[TBL] [Abstract][Full Text] [Related]
19. Influence of polypharmacy in the simultaneous presence of high pharmacotherapeutic complexity, drug interactions and non-adherence to medication in patients with HIV infection. Project 3-HIT.
Contreras-Macías E; Gutiérrez-Pizarraya A; Morillo-Verdugo R
Enferm Infecc Microbiol Clin (Engl Ed); 2023; 41(6):342-347. PubMed ID: 36175284
[TBL] [Abstract][Full Text] [Related]
20. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
Grierson J; Koelmeyer RL; Smith A; Pitts M
HIV Med; 2011 Oct; 12(9):562-9. PubMed ID: 21554524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
